|Articles|June 15, 2021
Analyzing SARS-CoV-2 Drugs Remdesivir and GS-441524
Author(s)YMC Europe GmbH
A fast separation of remdesivir and its active metabolite GS-441524 for the treatment of COVID-19 is obtained in only 3 minutes using a YMC-Triart C18 UHPLC column.
Related Content
Trending on LCGC International
1
How AI and Machine Learning Are Reshaping Separations Science at HPLC 2026
2
GC-MS Detection of Microbes in Spacecraft Water
3
GC-MS & GC-IMS Reveal Black Tea Aroma Secrets
4
ASMS 2026 Award Winners Highlight the Future of Mass Spectrometry
5